From: Antithrombotic treatment in elderly patients with atrial fibrillation: a practical approach
Temporary interruption | â—‹ Acute major bleeding (life-threatening hemorrhage, bleeding leading to hospital admission or need for blood transfusion). |
â—‹ Before elective surgery. | |
â—‹ Before endoscopic procedures with high risk of hemorrhage | |
Permanent discontinuation | â—‹ Hypersensitivity or intolerance to the drug. |
â—‹ Refusal of patient. | |
â—‹ Medication non-adherence. | |
â—‹ Poor short-term prognosis. | |
â—‹ Advanced or terminal cancer. | |
â—‹ Poor functional status with total dependency. | |
â—‹ Advanced cognitive impairment. | |
â—‹ Lack of social support that assure adequate drug compliance. | |
â—‹ High risk of bleeding. | |
â—‹ Retinopathy with high risk of bleeding. | |
â—‹ Hepatic disease associated with coagulopathy and clinically relevant bleeding risk. | |
â—‹ Alcohol abuse. | |
Conditions that do not justify anticoagulation withdrawal (but caution should be taken). | â—‹ Comorbidities or frailty do not contraindicate anticoagulation. However, life expectancy, functionality or cognitive impairment, among others, should be considered. |
â—‹ Risk of falls. | |
â—‹ Age (elderly). | |
â—‹ Previous intracranial bleeding is not an absolute contraindication, except when high risk of recurrence persists. If anticoagulation is considered, DOACs should be preferred over VKA. | |
â—‹ History of bleeding, particularly when the cause is eliminated. | |
â—‹ Need for dual antiplatelet therapy (i.e. after stent implantation). | |
â—‹ Concomitant use of nonsteroidal anti-inflammatory drugs. |